Mark C Wiggins - Net Worth and Insider Trading
Mark C Wiggins Net Worth
The estimated net worth of Mark C Wiggins is at least $4 Million dollars as of 2024-11-13. Mark C Wiggins is the EVP Corp. and Bus. Dev. of Biogen Inc and owns about 22,780 shares of Biogen Inc (BIIB) stock worth over $4 Million. Mark C Wiggins is the Director of Zogenix Inc and owns about 2,500 shares of Zogenix Inc (ZGNX) stock worth over $66,700. Mark C Wiggins is also the Chief Business Officer of TRACON Pharmaceuticals Inc and owns about 685 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $40. Details can be seen in Mark C Wiggins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark C Wiggins has not made any transactions after 2020-12-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark C Wiggins
Mark C Wiggins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark C Wiggins owns 3 companies in total, including TRACON Pharmaceuticals Inc (TCON) , Zogenix Inc (ZGNX) , and Biogen Inc (BIIB) .
Click here to see the complete history of Mark C Wiggins’s form 4 insider trades.
Insider Ownership Summary of Mark C Wiggins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2020-12-29 | Chief Business Officer |
| ZGNX | Zogenix Inc | 2020-05-29 | director |
| BIIB | Biogen Inc | 2008-09-26 | EVP Corp. and Bus. Dev. |
Mark C Wiggins Latest Holdings Summary
Mark C Wiggins currently owns a total of 3 stocks. Among these stocks, Mark C Wiggins owns 22,780 shares of Biogen Inc (BIIB) as of September 26, 2008, with a value of $4 Million and a weighting of 98.29%. Mark C Wiggins owns 2,500 shares of Zogenix Inc (ZGNX) as of March 23, 2020, with a value of $66,700 and a weighting of 1.71%. Mark C Wiggins also owns 685 shares of TRACON Pharmaceuticals Inc (TCON) as of December 29, 2020, with a value of $40 and a weighting of 0%.
Latest Holdings of Mark C Wiggins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIIB | Biogen Inc | 2008-09-26 | 22,780 | 168.28 | 3,833,418 |
| ZGNX | Zogenix Inc | 2020-03-23 | 2,500 | 26.68 | 66,700 |
| TCON | TRACON Pharmaceuticals Inc | 2020-12-29 | 685 | 0.06 | 40 |
Holding Weightings of Mark C Wiggins
Mark C Wiggins Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 734 shares on September 26, 2008, which brought Mark C Wiggins around $36,700.
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 1 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zogenix Inc is the acquisition of 2,500 shares on March 23, 2020, which cost Mark C Wiggins around $51,200.
According to the SEC Form 4 filings, Mark C Wiggins has made a total of 3 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 50 shares on December 29, 2020, which cost Mark C Wiggins around $10,570.
Insider Trading History of Mark C Wiggins
- 1
Mark C Wiggins Trading Performance
GuruFocus tracks the stock performance after each of Mark C Wiggins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark C Wiggins is 11.45%. GuruFocus also compares Mark C Wiggins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark C Wiggins within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark C Wiggins's insider trading performs compared to the benchmark.
Performance of Mark C Wiggins
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.5 | | | | | |
| Relative Return to S&P 500(%) | 1.2 | | | | | |
Mark C Wiggins Ownership Network
Ownership Network List of Mark C Wiggins
Ownership Network Relation of Mark C Wiggins
Mark C Wiggins Owned Company Details
What does TRACON Pharmaceuticals Inc do?
Who are the key executives at TRACON Pharmaceuticals Inc?
Mark C Wiggins is the Chief Business Officer of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .
TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary
Over the past 18 months, Mark C Wiggins made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.
TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.
TRACON Pharmaceuticals Inc Insider Transactions
Mark C Wiggins Mailing Address
Above is the net worth, insider trading, and ownership report for Mark C Wiggins. You might contact Mark C Wiggins via mailing address: 12671 High Bluff Drive Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
